Mass Tort News7 min readGLP-1 Rule 702 Hearing: What Sept. 10-18 DecidesJudge Marston holds a Rule 702 hearing Sept. 10-18, 2026 on whether GLP-1 causation experts can testify in MDL 3094, where 3,928 cases are pending.mass tortGLP-1Ozempic+5Sep 3, 2026Read
Guides & Resources6 min readProof of Use and Injury for Mass Tort ClaimsNavy says 88% of Camp Lejeune claims still lack DOJ evidence. A 2026 guide to proof of use and proof of injury by docket type.mass tortmedical recordsCamp Lejeune+4Aug 18, 2026Read
Mass Tort News8 min readGLP-1 Vision Loss MDL Grows 70% Ahead of September HearingsThe GLP-1 NAION vision-loss MDL hit 146 cases on the July JPML report (up 70% in two months) as the GI-injury MDL heads to Rule 702 hearings September 10-18.mass tortGLP-1Ozempic+4Jul 10, 2026Read
Mass Tort News6 min readNew GLP-1 Pill Approved as Ozempic MDL Nears TrialFDA approves Eli Lilly's Foundayo (the first oral GLP-1 with no fasting requirement) as 3,363 pending GLP-1 lawsuits approach critical deadlines.mass tortGLP-1Ozempic+2Apr 7, 2026Read
Legal Updates7 min readFDA Warns Novo Nordisk on Unreported DeathsFDA cites 'systemic failures' in Novo Nordisk's adverse event reporting for Ozempic and Wegovy, including unreported patient deaths.OzempicFDAmass tort+2Mar 24, 2026Read
Mass Tort News6 min read4,400 GLP-1 Lawsuits Filed: What Firms Need to KnowGLP-1 drug lawsuits surged 130% in 2025, with 75% alleging gastroparesis. A Rule 702 expert hearing is set for September 2026.mass tortGLP-1Ozempic+2Feb 3, 2026Read
